Hepatitis B virus (HBV) infection has shown an intermediate or high endemicity level in low-
income countries over the last five decades. In recent years, however, the incidence of acute …

The pace of therapeutic advances in the treatment of chronic viral hepatitis, such as hepatitis
B and hepatitis C, has accelerated significantly in the past decade. The hepatitis B virus …

Background Chronic infection with hepatitis B virus (HBV) is associated with a high lifetime
risk of developing hepatocellular carcinoma (HCC) and cirrhosis of the liver. Purpose To …

The origin of hepatitis B virus (HBV) infection in humans and other primates remains largely
unresolved. Understanding the origin of HBV is crucial because it provides a framework for …

This multicentric population-based study in Brazil is the first national effort to estimate the
prevalence of hepatitis B (HBV) and risk factors in the capital cities of the Northeast, Central …

Although chronic HBV infection is the leading cause of chronic liver disease and death
worldwide, there are substantial differences in its clinical courses regarding prevalence …

Understanding the evolutionary history of human viruses, along with the factors that have
shaped their spatial distributions, is one of the most active areas of study in the field of …

Chronic hepatitis B virus infection (HBV) continues to pose a serious global health threat in
many areas of the world, particularly in sub-Saharan Africa, the Western Pacific Region and …

Abstract Background Hepatitis B virus (HBV) isolates have been classified in eight
genotypes, A to H, which exhibit distinct geographical distributions. Genotypes A, D and F …

Hepatitis B virus (HBV) infection is the leading cause of severe chronic liver disease. This
article provides a critical view of the importance of genomic medicine for the study of HBV …